auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Laurent Pharmaceuticals Inc.Department
National Research Council CanadaAmount
$10.0M
Province
QCType
Contribution
Agreement Number
172-2020-2021-Q3-958708
Purpose
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
Laurent Pharmaceuticals Inc. × National Research Council Canada
14 grants totalling $53.9M
Industrial Research Assistance Program – Contributions to Firms
26,784 grants totalling $5.1B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| ILLUMIN INC. | $10.0M | Industrial Research Assistance Program –... |